- Home
- ALVO vs NEO Comparison
ALVO vs NEO Comparison
Compare ALVO & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALVO | NEO |
|---|---|---|
| Founded | 2013 | 2001 |
| Country | Luxembourg | United States |
| Employees | 1460 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | ALVO | NEO |
|---|---|---|
| Price | $3.25 | $8.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | $8.00 | ★ $13.38 |
| AVG Volume (30 Days) | 384.9K | ★ 2.1M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.28 | $10.63 |
| Revenue Next Year | $18.63 | $9.73 |
| P/E Ratio | $18.20 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.03 | $4.72 |
| 52 Week High | $11.85 | $13.74 |
Technical Indicators
Market Signals| Indicator | ALVO | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 42.80 | 46.83 |
| Support Level | $3.10 | $7.50 |
| Resistance Level | $3.83 | $8.84 |
| Average True Range (ATR) | 0.20 | 0.55 |
| MACD | -0.00 | -0.07 |
| Stochastic Oscillator | 13.27 | 10.44 |
Price Performance
Historical ComparisonAbout ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.